Par Pharmaceutical Companies (PRX)
Par Pharmaceutical Companies Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 39.29% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -10.58% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.735 |
| Debt to Equity Ratio | 0.5806 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -15.35% |
| Year to Date Stock Returns | 9.50% |
| 1 Year Stock Returns | 4.31% |
| 3 Year Stock Returns | 168.5% |
| 52 Week High | 42.80 |
| 52 Week Low | 24.85 |
Income Statement
| Revenues TTM | 964.66M |
| Revenue Per Share TTM | 26.38 |
| Revenue Growth | 16.54% |
| Gross Profit TTM | 394.10M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | 54.10M |
| Earnings Per Share TTM | 1.55 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -485.71M |
| Cash Financing TTM | 337.06M |
| Cash Operations TTM | 49.36M |
| Capital Expenditures | 3.545M |
Share Statistics
| Shares Outstanding | 36.57M |
Balance Sheet
| Cash and ST Investments | 186.51M |
| Total Assets | 1.254B |
| Liabilities | 666.52M |
| Book Value | 587.76M |
| Book Value per Share | 16.07 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 341.25M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these PRX related companies
PRX News
Barclays Cuts Estimates on Par Pharmaceutical (PRX); Removing Lovaza Contribution From Model
May 31, 2:11PM Street Insider
May 31, 2:11PM Street Insider
Teva Pharmaceutical Inds, VeriFone Systems Among Stocks Down on Above-average Volume Tuesday
May 29, 4:34PM Fox Business
May 29, 4:34PM Fox Business
$PRX Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 2 days ago by abubnic
about 2 days ago by abubnic
Teva (TEVA), Par Pharma (NPRX) said to lose bid to sell the generic form of Glaxo's (GSK) Lovaza
May 29, 3:20PM Street Insider
May 29, 3:20PM Street Insider
RT @TraderRadar $AAPL $NFLX $PRX Keep these on your radar for higher prices next week// $NFLX based on what evidence??
about 6 days ago by lipong23
about 6 days ago by lipong23
$AAPL $NFLX $PRX Keep these on your radar for higher prices next week
about 6 days ago by TraderRadar
about 6 days ago by TraderRadar
@TraderRadar Like $PRX - should keep moving after pull back to $39 area
about 6 days ago by OMillionaires
about 6 days ago by OMillionaires
UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Comments From Conference Call
May 09, 12:21PM Street Insider
May 09, 12:21PM Street Insider
Listen to $PRX Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3iVK
about 23 days ago by earningscast
about 23 days ago by earningscast
Also sold my $HMSY on weakness. Picked up shares of $PRX Friday. Any thoughts?
about 40 days ago by robertfreedland
about 40 days ago by robertfreedland
Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Healthy Deal with Handa
Apr 20, 9:46AM Street Insider
Apr 20, 9:46AM Street Insider
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.
Apr 19, 3:05PM Benzinga
Apr 19, 3:05PM Benzinga
Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012
Apr 09, 9:00AM PR Newswire
Apr 09, 9:00AM PR Newswire
$PRX is 5.0% up since open on unusual high volume and 5.5% up since close.
about 56 days ago by TradeBot
about 56 days ago by TradeBot
$WCG $CL $SJM $PRX Hit 52-Week Highs http://stks.co/39sz My story via @TheStreet #52WeekHigh
about 62 days ago by azendrian
about 62 days ago by azendrian
$PRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39RA
about 62 days ago by MarketBrief
about 62 days ago by MarketBrief
Horizon Pharma (HZNP) Files Patent Infringement Suit Against Par Pharma (PRX) Over DUEXIS Tabs
Mar 28, 4:30PM Street Insider
Mar 28, 4:30PM Street Insider
$PRX forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/33Pn
about 69 days ago by RecogniaEvents
about 69 days ago by RecogniaEvents
Impressive development programs, partnerships and product launch prep make IntelGenX look like a solid bet at these prices
Mar 23, 8:34AM Thomson Reuters ONE
Mar 23, 8:34AM Thomson Reuters ONE
$PRX forms bearish "Triple Top" chart pattern. http://stks.co/2epQ
about 90 days ago by RecogniaEvents
about 90 days ago by RecogniaEvents
Listen to $PRX Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2af5
about 93 days ago by earningscast
about 93 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRX | 35.84 | -1.17 | -3.16% | 1.353B |
| PRWTD | 1.51 | -0.04 | -2.58% | |
| PRWT | 1.51 | -0.04 | -2.58% | 15.15M |
| PRU | 46.45 | -0.20 | -0.43% | 21.92B |
| PLL | 55.65 | -0.76 | -1.35% | 6.510B |
| PLG | 1.19 | -0.01 | -0.83% | 213.11M |
| PLFE | 8.84 | +0.04 | +0.45% | 260.30M |
| PLD | 32.00 | +0.21 | +0.66% | 14.62B |
| PLCM | 11.45 | -0.13 | -1.12% | 2.055B |
| PATR | 20.39 | -0.73 | -3.46% | 189.83M |
